Hyperlipidaemia and Hypertrophic cardiomyopathy

Summary:

Hypertrophic cardiomyopathy is found among people with Hyperlipidaemia, especially for people who are female, 60+ old.

The study analyzes which people have Hypertrophic cardiomyopathy with Hyperlipidaemia. It is created by eHealthMe based on reports of 11 people who have Hyperlipidaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hyperlipidaemia?

Hyperlipidaemia (presence of excess lipids in the blood) is found to be associated with 1,428 drugs and 1,407 conditions by eHealthMe. Check the latest studies of Hyperlipidaemia.

What is Hypertrophic cardiomyopathy?

Hypertrophic cardiomyopathy (a condition in which the heart muscle becomes abnormally thick) is found to be associated with 265 drugs and 936 conditions by eHealthMe. Check the latest studies of Hypertrophic cardiomyopathy.



On Jul, 11, 2026

11 people who have Hyperlipidaemia and Hypertrophic Cardiomyopathy are studied.

Would you have Hypertrophic cardiomyopathy when you have Hyperlipidaemia?

Gender of people who have Hyperlipidaemia and experienced Hypertrophic Cardiomyopathy *:

  • female: 60 %
  • male: 40 %

Age of people who have Hyperlipidaemia and experienced Hypertrophic Cardiomyopathy *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 20 %
  • 50-59: 0.0 %
  • 60+: 80 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 6 people, 54.55%
  2. Menopausal Symptoms: 4 people, 36.36%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 27.27%
  4. Osteoporosis (bones weak and more likely to break): 3 people, 27.27%
  5. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 18.18%
  6. Cardiac Failure: 2 people, 18.18%
  7. Cardioplegia (intentional and temporary cessation of cardiac activity): 2 people, 18.18%
  8. Constipation: 2 people, 18.18%
  9. Diabetes: 2 people, 18.18%
  10. Stable Angina (a constant chest pain): 2 people, 18.18%

Common drugs taken by these people *:

  1. Lipitor: 4 people, 36.36%
  2. Pravachol: 4 people, 36.36%
  3. Cardizem Cd: 4 people, 36.36%
  4. Catapres-Tts-1: 4 people, 36.36%
  5. Zocor: 4 people, 36.36%
  6. Diltiazem Hydrochloride: 4 people, 36.36%
  7. Toprol-Xl: 4 people, 36.36%
  8. Fosamax: 4 people, 36.36%
  9. Lansoprazole: 4 people, 36.36%
  10. Prilosec: 4 people, 36.36%

Common symptoms for these people *:

  1. Stress And Anxiety: 6 people, 54.55%
  2. Heart Attack: 5 people, 45.45%
  3. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 5 people, 45.45%
  4. Abdominal Adhesions (inflammation of abdomen): 4 people, 36.36%
  5. Cystocele (a condition that occurs when the tough fibrous wall between a woman's bladder and her vagina is torn by childbirth): 4 people, 36.36%
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 36.36%
  7. Oesophageal Stenosis (narrowing of oesophagus): 4 people, 36.36%
  8. Foot Deformity (functional disability of foot): 4 people, 36.36%
  9. Neuroma (tumour of nerve tissue): 4 people, 36.36%
  10. Cataract (clouding of the lens inside the eye): 4 people, 36.36%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hypertrophic cardiomyopathy?

- Check whether Hypertrophic cardiomyopathy is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hypertrophic cardiomyopathy:

All the conditions that are associated with Hypertrophic cardiomyopathy:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hypertrophic cardiomyopathy and Hyperlipidaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: